Log in

NYSE:RAD - Rite Aid Stock Price, Forecast & News

$13.49
-1.65 (-10.90 %)
(As of 02/26/2020 02:06 AM ET)
Today's Range
$13.41
Now: $13.49
$15.38
50-Day Range
$11.66
MA: $13.16
$16.04
52-Week Range
$5.04
Now: $13.49
$23.88
Volume5.32 million shs
Average Volume6.17 million shs
Market Capitalization$739.51 million
P/E RatioN/A
Dividend YieldN/A
Beta1.99
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. Read More…

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
CUSIP76775410
Phone717-761-2633

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.64 billion
Cash Flow$11.34 per share
Book Value$21.98 per share

Profitability

Net Income$-422,210,000.00

Miscellaneous

Employees51,000
Market Cap$739.51 million
Next Earnings Date4/9/2020 (Estimated)
OptionableOptionable

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.


Rite Aid (NYSE:RAD) Frequently Asked Questions

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

When did Rite Aid's stock split? How did Rite Aid's stock split work?

Shares of Rite Aid reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) issued its earnings results on Thursday, December, 19th. The company reported $0.54 EPS for the quarter, beating the Zacks' consensus estimate of $0.09 by $0.45. The firm had revenue of $5.46 billion for the quarter, compared to analysts' expectations of $5.42 billion. Rite Aid had a positive return on equity of 1.40% and a negative net margin of 1.86%. The business's revenue was up .2% compared to the same quarter last year. During the same quarter last year, the business earned $0.01 earnings per share. View Rite Aid's Earnings History.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release their next quarterly earnings announcement on Thursday, April 9th 2020. View Earnings Estimates for Rite Aid.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid issued an update on its FY20 earnings guidance on Thursday, December, 19th. The company provided EPS guidance of $0.13-0.55 for the period, compared to the Thomson Reuters consensus estimate of $0.18. The company issued revenue guidance of $21.5-21.9 billion, compared to the consensus revenue estimate of $21.64 billion.

What price target have analysts set for RAD?

3 brokers have issued 1-year price objectives for Rite Aid's stock. Their forecasts range from $12.00 to $12.00. On average, they expect Rite Aid's stock price to reach $12.00 in the next twelve months. This suggests that the stock has a possible downside of 11.0%. View Analyst Price Targets for Rite Aid.

What is the consensus analysts' recommendation for Rite Aid?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 3 sell ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Rite Aid.

Has Rite Aid been receiving favorable news coverage?

Press coverage about RAD stock has been trending extremely positive recently, InfoTrie reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rite Aid earned a daily sentiment score of 5.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Rite Aid.

Are investors shorting Rite Aid?

Rite Aid saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 17,850,000 shares, an increase of 23.3% from the January 15th total of 14,480,000 shares. Based on an average daily trading volume, of 6,500,000 shares, the days-to-cover ratio is currently 2.7 days. Approximately 33.9% of the shares of the company are sold short. View Rite Aid's Current Options Chain.

Who are some of Rite Aid's key competitors?

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Mr. Cooper Group (COOP), Cleveland-Cliffs (CLF), Advanced Micro Devices (AMD), General Electric (GE), Lantronix (LTRX) and AK Steel (AKS).

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:
  • Mr. John T. Standley, CEO & Director (Age 56)
  • Mr. Kermit Ray Crawford, Pres & COO (Age 60)
  • Mr. Bryan B. Everett, Chief Operating Officer (Age 46)
  • Mr. Darren Wayne Karst, Exec. Officer (Age 59)
  • Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy & Retail Operations (Age 49)

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (2.95%), Alberta Investment Management Corp (1.80%), Charles Schwab Investment Management Inc. (1.54%), Geode Capital Management LLC (1.33%), Creative Planning (1.01%) and Bank of New York Mellon Corp (0.56%). View Institutional Ownership Trends for Rite Aid.

Which institutional investors are selling Rite Aid stock?

RAD stock was sold by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, Creative Planning, Ladenburg Thalmann Financial Services Inc., State Street Corp, Cubist Systematic Strategies LLC, Alliancebernstein L.P., UBS Asset Management Americas Inc. and Stifel Financial Corp. View Insider Buying and Selling for Rite Aid.

Which institutional investors are buying Rite Aid stock?

RAD stock was acquired by a variety of institutional investors in the last quarter, including Charles Schwab Investment Management Inc., Geode Capital Management LLC, SG Americas Securities LLC, UBS Group AG, Bainco International Investors, Bank of New York Mellon Corp, Russell Investments Group Ltd. and Bank of America Corp DE. View Insider Buying and Selling for Rite Aid.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $13.49.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $739.51 million and generates $21.64 billion in revenue each year. Rite Aid employs 51,000 workers across the globe.View Additional Information About Rite Aid.

What is Rite Aid's official website?

The official website for Rite Aid is http://www.riteaid.com/.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]


MarketBeat Community Rating for Rite Aid (NYSE RAD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  755 (Vote Outperform)
Underperform Votes:  758 (Vote Underperform)
Total Votes:  1,513
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel